While the primary focus of the Guthrie Test is on phenylketonuria (PKU), it has been expanded to detect a range of metabolic disorders. These include congenital hypothyroidism, galactosemia, and maple syrup urine disease. The test can be modified to include other conditions based on regional prevalence and public health priorities.
